Cells,
Journal Year:
2020,
Volume and Issue:
9(10), P. 2253 - 2253
Published: Oct. 8, 2020
Female
infertility
is
a
global
medical
condition
that
can
be
caused
by
various
disorders
of
the
reproductive
system,
including
premature
ovarian
failure
(POF),
polycystic
ovary
syndrome
(PCOS),
endometriosis,
Asherman
syndrome,
and
preeclampsia.
It
affects
quality
life
both
patients
couples.
Mesenchymal
stem
cells
(MSCs)
have
received
increasing
attention
as
potential
cell-based
therapy,
with
several
advantages
over
other
cell
sources,
greater
abundance,
fewer
ethical
considerations,
high
capacity
for
self-renewal
differentiation.
Clinical
researchers
examined
therapeutic
use
MSCs
in
female
infertility.
In
this
review,
we
discuss
recent
studies
on
lead
to
We
also
describe
role
microRNAs
(miRNAs)
exosomal
miRNAs
controlling
MSC
gene
expression
driving
outcomes.
The
clinical
application
holds
great
promise
treatment
or
insufficiency,
improve
health
significant
number
women
worldwide.
Cells,
Journal Year:
2019,
Volume and Issue:
8(12), P. 1605 - 1605
Published: Dec. 11, 2019
There
is
growing
evidence
that
mesenchymal
stem
cell
(MSC)-based
immunosuppression
was
mainly
attributed
to
the
effects
of
MSC-derived
extracellular
vesicles
(MSC-EVs).
MSC-EVs
are
enriched
with
MSC-sourced
bioactive
molecules
(messenger
RNA
(mRNA),
microRNAs
(miRNAs),
cytokines,
chemokines,
immunomodulatory
factors)
regulate
phenotype,
function
and
homing
immune
cells.
In
this
review
article
we
emphasized
current
knowledge
regarding
molecular
mechanisms
responsible
for
therapeutic
in
attenuation
autoimmune
inflammatory
diseases.
We
described
disease-specific
cellular
targets
defined
molecules,
which
were
MSC-EV-based
immunosuppression.
Results
obtained
a
large
number
experimental
studies
revealed
both
local
systemic
administration
efficiently
suppressed
detrimental
response
inflamed
tissues
promoted
survival
regeneration
injured
parenchymal
MSC-EVs-based
anti-inflammatory
relied
on
delivery
immunoregulatory
miRNAs
proteins
cells
(M1
macrophages,
dendritic
(DCs),
CD4+Th1
Th17
cells),
enabling
their
phenotypic
conversion
into
immunosuppressive
M2
tolerogenic
DCs
T
regulatory
Additionally,
through
mRNAs
miRNAs,
activated
autophagy
and/or
inhibited
apoptosis,
necrosis
oxidative
stress
hepatocytes,
neurons,
retinal
cells,
lung,
gut
renal
epithelial
promoting
regeneration.
Theranostics,
Journal Year:
2020,
Volume and Issue:
10(13), P. 5979 - 5997
Published: Jan. 1, 2020
Mesenchymal
stem/stromal
cells
(MSCs)
are
important
players
in
tissue
homeostasis
and
regeneration
owing
to
their
immunomodulatory
potential
release
of
trophic
factors
that
promote
healing.They
have
been
increasingly
used
clinical
trials
treat
multiple
conditions
associated
with
inflammation
damage
such
as
graft
versus
host
disease,
orthopedic
injuries
cardiac
liver
diseases.Recent
evidence
demonstrates
beneficial
effects
derived,
at
least
part,
from
secretome.In
particular,
data
animal
models
first-in-man
studies
indicate
MSC-derived
extracellular
vesicles
(MSC-EVs)
can
exert
similar
therapeutic
origin.MSC-EVs
membranous
structures
loaded
proteins,
lipids,
carbohydrates
nucleic
acids,
which
play
an
role
cell-cell
communication
may
represent
attractive
alternative
for
cell-based
therapy.In
this
article
we
summarize
recent
advances
the
use
MSC-EVs
repair.We
highlight
several
isolation
characterization
approaches
enrich
EVs.We
discuss
our
current
understanding
relative
contribution
regenerative
mediated
by
MSCs
MSC
secretome.Finally
challenges
opportunities,
come
cell
free
therapy
require
repair.
Stem Cells International,
Journal Year:
2020,
Volume and Issue:
2020, P. 1 - 12
Published: March 9, 2020
The
role
of
the
mesenchymal
stromal
cell-
(MSC-)
derived
secretome
is
becoming
increasingly
intriguing
from
a
clinical
perspective
due
to
its
ability
stimulate
endogenous
tissue
repair
processes
as
well
effective
regulation
immune
system,
mimicking
therapeutic
effects
produced
by
MSCs.
composite
product
secreted
MSC
in
vitro
(in
conditioned
medium)
and
vivo
extracellular
milieu),
consisting
protein
soluble
fraction
(mostly
growth
factors
cytokines)
vesicular
component,
vesicles
(EVs),
which
transfer
proteins,
lipids,
genetic
material.
MSC-derived
differs
based
on
MSCs
are
isolated
under
specific
conditions
(e.g.,
preconditioning
or
priming)
suggesting
that
applications
should
be
tailored
choosing
origin
priming
regimen
specifically
correct
given
pathology.
mediates
beneficial
angiogenic
variety
injury-related
diseases.
This
supports
current
effort
develop
cell-free
products
bring
both
benefits
(reduced
immunogenicity,
persistence
vivo,
no
genotoxicity
associated
with
long-term
cell
cultures)
manufacturing
advantages
costs,
availability
large
quantities
off-the-shelf
products,
lower
regulatory
burden).
In
present
review,
we
aim
give
comprehensive
picture
numerous
components
most
common
sources
for
use
AT,
BM,
CB).
We
focus
involved
complex
processes.
Stem Cell Research & Therapy,
Journal Year:
2020,
Volume and Issue:
11(1)
Published: May 27, 2020
Exosomes
derived
from
mesenchymal
stem
cells
(MSC-exos)
have
been
demonstrated
with
great
potential
in
the
treatment
of
multiple
human
diseases
including
acute
kidney
injury
(AKI)
by
virtue
their
intrinsic
cargoes.
However,
there
are
major
challenges
low
yield
and
lack
an
established
biomanufacturing
platform
to
efficiently
produce
MSC-exos,
thereby
limiting
therapeutic
application.
Here,
we
aimed
establish
a
novel
strategy
MSC-exos
hollow
fiber
bioreactor-based
three-dimensional
(3D)
culture
system
evaluate
efficacy
3D-exosomes
(3D-exos)
on
AKI.Mesenchymal
(MSCs)
were
isolated
fresh
umbilical
cord
cultured
two-dimensional
(2D)
flasks.
2
×
108
MSCs
inoculated
into
bioreactor
for
3D
culture.
The
supernatants
collected
every
1
or
days
isolating
exosomes.
2D
(2D-exos)
cultures
characterized
transmission
electron
microscopy,
nanoparticle
tracking
analysis,
western
blotting
analysis
exosome
markers.
exosomes
seeded
was
compared,
based
protein
quantification.
2D-exos
3D-exos
investigated
murine
model
cisplatin-induced
AKI
vivo
vitro.3D
did
not
significantly
change
surface
markers
MSCs,
as
well
morphology,
size,
exosomal
when
compared
those
2D-exos.
Compared
conventional
culture,
increased
total
production
up
19.4-fold.
more
concentrated
harvested
(15.5-fold)
than
2D-exos,
which
led
higher
collection
efficiency
system.
In
vivo,
both
alleviated
evidenced
improved
renal
function,
attenuated
pathological
changes
tubules,
reduced
inflammatory
factors,
repressed
T
cell
macrophage
infiltration.
Impressively,
effective
Moreover,
taken
tubular
epithelial
(TECs)
efficiency,
exhibiting
superior
anti-inflammatory
effect
viability
TECs
vitro.In
summary,
our
findings
demonstrate
that
provides
efficient
continuous
has
enhanced
AKI.
Frontiers in Immunology,
Journal Year:
2021,
Volume and Issue:
12
Published: Sept. 27, 2021
Recent
years,
the
immunosuppressive
properties
of
mesenchymal
stem
cells
(MSCs)
have
been
demonstrated
in
preclinical
studies
and
trials
inflammatory
autoimmune
diseases.
Emerging
evidence
indicates
that
immunomodulatory
effect
MSCs
is
primarily
attributed
to
paracrine
pathway.
As
one
key
effectors,
cell-derived
exosomes
(MSC-EXOs)
are
small
vesicles
30-200
nm
diameter
play
an
important
role
cell-to-cell
communication
by
carrying
bioactive
substances
from
parental
cells.
support
finding
MSC-EXOs
obvious
inhibitory
toward
different
effector
involved
innate
adaptive
immune
response.
Moreover,
substantial
progress
has
made
treatment
diseases,
including
multiple
sclerosis
(MS),
systemic
lupus
erythematosus
(SLE),
type-1
diabetes
(T1DM),
uveitis,
rheumatoid
arthritis
(RA),
bowel
disease
(IBD).
capable
reproducing
MSC
function
overcoming
limitations
traditional
cell
therapy.
Therefore,
using
instead
treat
diseases
appears
be
a
promising
cell-free
strategy.
In
this
review,
we
review
current
understanding
discuss
regulatory
on
its
potential
application
Molecular Pharmaceutics,
Journal Year:
2020,
Volume and Issue:
17(5), P. 1723 - 1733
Published: April 1, 2020
Diabetic
wounds
are
a
worldwide
health
problem
causing
extremely
heavy
public
burden
and
require
effective
treatment.
Optimal
strategies
for
treating
nonhealing
diabetic
include
stem-cell-based
therapy
delivery
of
novel
drug
substances,
such
as
functional
microRNAs
(miRNAs);
however,
miRNA
easily
degrades
in
the
wound
microenvironment.
Herein,
we
developed
human
adipose
stem-cell-derived
exosome
(hASC-exos)-based
strategy
to
enhance
its
therapeutic
efficacy.
The
miR-21-5p
mimics,
candidates
wounds,
were
loaded
into
hASC-exos
by
electroporation,
taking
advantage
natural
availability
biocompatibility
exosomes
extracellular
transporting
particles.
engineered
(E-exos)
exhibited
excellent
effects
on
promoting
proliferation
migration
keratinocytes
via
Wnt/β-catenin
signaling
vitro
accelerating
healing
increasing
re-epithelialization,
collagen
remodeling,
angiogenesis,
vessel
maturation
vivo.
Results
from
this
study
would
set
fundamentals
applying
deliver
future
substances
develop
cell-free
wound-healing
treatments.
Advanced Healthcare Materials,
Journal Year:
2021,
Volume and Issue:
10(7)
Published: Jan. 12, 2021
Abstract
Mesenchymal
stem
cells
(MSCs)
have
been
widely
studied
as
a
versatile
cell
source
for
tissue
regeneration
and
remodeling
due
to
their
potent
bioactivity,
which
includes
modulation
of
inflammation
response,
macrophage
polarization
toward
proregenerative
lineage,
promotion
angiogenesis,
reduction
in
fibrosis.
This
review
focuses
on
profiling
the
effects
paracrine
signals
MSCs,
commonly
referred
secretome,
highlighting
various
engineering
approaches
tune
MSC
secretome.
Recent
advances
biomaterials‐based
therapeutic
strategies
delivery
MSCs
MSC‐derived
secretome
form
extracellular
vesicles
are
discussed,
along
with
advantages
challenges.
Cell Communication and Signaling,
Journal Year:
2020,
Volume and Issue:
18(1)
Published: Sept. 11, 2020
Exosomes
are
extracellular
vesicles
characterized
by
their
size,
source,
release
mechanism
and
contents.
MicroRNAs
(miRNAs)
single
stranded
non-coding
RNAs
transcribed
from
DNA.
miRNAs
widespread
in
eukaryotic
cells,
especially
mesenchymal
stem
cells
(MSCs).
MSCs
used
for
tissue
regeneration,
also
exert
paracrine,
anti-inflammatory
immunomodulatory
effects.
However,
the
use
of
is
controversial,
presence
or
after
remission
a
tumor,
due
to
secretion
growth
factors
migration
ability.
Instead
intact
MSCs,
MSC-derived
compartments
substances
could
be
as
practical
tools
diagnosis,
follow
up,
management
monitoring
diseases.
Herein,
we
discuss
some
aspects
exosomal
derived
progression,
diagnosis
treatment
various
Video
Abstract.
International Journal of Molecular Sciences,
Journal Year:
2020,
Volume and Issue:
21(19), P. 7038 - 7038
Published: Sept. 24, 2020
The
use
of
mesenchymal
stem
cells
(MSC)
for
the
treatment
cutaneous
wounds
is
currently
enormous
interest.
However,
broad
translation
cell
therapies
into
clinical
hampered
by
their
efficacy,
safety,
manufacturing
and
cost.
MSCs
release
a
repertoire
trophic
factors
immunomodulatory
cytokines,
referred
to
as
MSC
secretome,
that
has
considerable
potential
cell-free
therapy.
In
this
review,
we
outline
current
status
introduce
secretome
alternative
wound
repair.
We
discuss
challenges
provide
insights
perspectives
future
development
well
identify
its
therapeutic
treatment.